Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing
Alessia Manni, Florian Oggiano, C. Palazzo, Valentina Panetta, Concetta Domenica Gargano, Vincenzo Mangialardi, Tommaso Guerra, Antonio Iaffaldano, Francesca Caputo, Pietro Iaffaldano, Maddalena Ruggieri, María Trojano, Damiano Paolicelli
Topics & Concepts
CladribineMultiple sclerosisMedicineDosingInternal medicineInterval (graph theory)ImmunologyCombinatoricsMathematicsMultiple Sclerosis Research StudiesAmyotrophic Lateral Sclerosis ResearchMultiple Myeloma Research and Treatments